Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,268,535 papers from all fields of science
Search
Sign In
Create Free Account
HMR1726
Known as:
HMR 1726
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
teriflunomide
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Teriflunomide for the Treatment of Relapsing Multiple Sclerosis
L. Brunetti
,
M. Wagner
,
Megan E. Maroney
,
M. Ryan
The Annals of Pharmacotherapy
2013
Corpus ID: 20032425
Objective: To review the pharmacology and clinical data for teriflunomide in relapsing multiple sclerosis (MS). Data Sources: A…
Expand
Review
2011
Review
2011
Emerging oral drugs for relapsing–remitting multiple sclerosis
C. Gasperini
,
S. Ruggieri
Expert Opinion on Emerging Drugs
2011
Corpus ID: 19479681
Introduction: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS), traditionally…
Expand
2006
2006
The Active form of Leflunomide, HMR1726, Facilitates TNF-a and IL-17 Induced MMP-1 and MMP-3 Expression
D. Alexander
,
B. Friedrich
,
Tanja Abruzzese
,
B. Gondolph-Zink
,
Nikolaus Wülker
,
W. Aicher
Cellular Physiology and Biochemistry
2006
Corpus ID: 25872375
Background/Aims: To elucidate the influence and mode of action of HMR1726 (the active metabolite of leflunomide) on TNF-a and IL…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE